Property Name |
Property Value |
Unit |
Raw Value |
Raw Unit |
Annotation |
Reference |
AUC |
113.0 |
ng.h/ml |
113±38 |
ng.h/ml |
IM,intramuscular injection; |
DRUGBANK |
AUC |
331.0 |
ng.h/ml |
331±50 |
ng.h/ml |
PO, oral; |
DRUGBANK |
Bioavailability |
74.0 |
% |
70-78 |
% |
PO, oral; |
DRUGBANK |
C Max |
34.6 |
ng/ml |
34.6±6.0 |
ng/ml |
IM,intramuscular injection; |
DRUGBANK |
C Max |
13.9 |
ng/ml |
13.9±6.8 |
ng/ml |
PO, oral; |
DRUGBANK |
T Max |
2.0 |
h |
2.0±1.2 |
h |
IM,intramuscular injection; |
DRUGBANK |
T Max |
2.0 |
h |
2.0±0.5 |
h |
PO, oral; |
DRUGBANK |
Clearance |
15.7 |
L/h |
15.7 |
L/h |
Tablet, PO, oral; |
DRUGBANK |
Clearance |
15.6 |
L/h |
15.6±4.9 |
L/h |
PO, oral; |
DRUGBANK |
Clearance |
9.9 |
L/h |
9.9±1.4 |
L/h |
IM,intramuscular injection; |
DRUGBANK |
Clearance |
0.20 |
L/h/kg |
3.3 |
ml/min/kg |
intravenous injection, IV; human, homo sapiens; |
Human Intravenous Pharmacokinetic Dataset |
Volume of Distribution |
51.0 |
L |
51.0 |
L |
PO, oral; |
DRUGBANK |
Volume of Distribution |
96.0 |
L |
96.0 |
L |
IM,intramuscular injection; |
DRUGBANK |
Volume of Distribution |
0.94 |
L/kg |
0.94 |
L/kg |
intravenous injection, IV; human, homo sapiens; |
Human Intravenous Pharmacokinetic Dataset |
Half-life |
4.0 |
h |
4 |
h |
terminal half-life; Tablet, PO, oral; |
DRUGBANK |
Half-life |
6.6 |
h |
6.6±4.3 |
h |
PO, oral; |
DRUGBANK |
Half-life |
4.2 |
h |
4.2±1.2 |
h |
IM,intramuscular injection; |
DRUGBANK |
Half-life |
3.7 |
h |
3.7 |
h |
intravenous injection, IV; human, homo sapiens; |
Human Intravenous Pharmacokinetic Dataset |
Toxicity LD50 |
6500.0 |
mg/kg |
6.5 |
g/kg |
PO, oral; female mouse; |
DRUGBANK |
Toxicity LD50 |
794.0 |
mg/kg |
794.0 |
mg/kg |
intravenous injection, IV; female mouse; |
DRUGBANK |
Toxicity LD50 |
3000.0 |
mg/kg |
>3 |
g/kg |
PO, oral; Rattus, Rat; |
T3DB |
Protein Binding |
77.0 |
% |
~77 |
% |
plasma proteins; |
DRUGBANK |